Ozempic maker struggles as it loses ground to rivals in weight-loss market
Ozempic制造商在减肥市场上失去竞争优势，陷入困境
Novo Nordisk, which makes Ozempic as well as Wegovy, predicts full-year operating profit to grow by up to 7% in 2025, compared with an earlier forecast of 16%.
2025-11-05 515词 中等
“The market is more competitive than ever more,” Doustdar said in a video message accompanying the company’s third-quarter results.
免责声明：本文来自网络公开资料，仅供学习交流，其观点和倾向不代表本站立场。